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TRYPANOSOMA  CRUZI:  MECHANISM OF ENTRY AND 
INTRACELLULAR FATE  IN MAMMALIAN CELLS* 
BY NADIA NOGUEIRA AND ZANVIL COHN 
(From The Rockefeller  University,  New York 10021) 
The factors  involved in  the resistance  or  susceptibility  of  mammalian hosts  to 
infection  with Trypanosoma  cruzi remain obscure.  A more detailed  analysis  of 
the interactions  of  the  parasite  and  host  cells  would provide  a  better  understand- 
ing of  the pathogenesis of  this  infection.  Several investigators  have examined 
the mode of  entry,  intracellular  development, and  fate  of  T. cruzi in  a variety  of 
cells  using  both  light  and  electron  microscopic  techniques,  but  the  result  of  these 
studies  are contradictory  (1-11). 
We report  here our  studies  on the mode of  entry and fate  of  both  epimastigote 
and trypomastigote forms ofT. cruzi at  the light  and electron  microscope levels. 
The observations were mainly performed with mouse peritoneal  macrophages, 
although parallel  studies on several cultured  cell  types (HeLa, L cells,  calf 
embryo fibroblasts)  will  also  be described.  Utilizing  a technique to separate the 
cultured  forms of  epimastigotes and trypornastigotes  (12),  we were then able to 
study their  different  fates  as well as the components of the host cell  plasma 
membrane involved in the interiorization  process.  Some of  these  results  have 
been previously  published in abstract  form (13). 
Materials and Methods 
Parasites.  The Y  strain of T. cruzi was obtained from Dr. S.  C.  Correa  (Instituto Oswaldo 
Cruz, Rio de Janeiro, Brazil). The PF strain was obtained from Dr. Z. Brenner (Funda¢&o I. O. 
Cruz, Belo Horizonte, MG, Brazil) and the Tulahuen strain from Dr. B. Bloom (Albert Einstein 
School of Medicine, Bronx, N. Y.). The parasites were grown in Tobie's medium and passed weekly 
(14).  Parasites  were harvested  from 8-day-old cultures,  washed twice with phosphate-buffered 
saline (PBS)  1 (Dulbecco's, Grand Island Biological Co., Grand Island, N. Y.) at 750g for 20 rain, 
resuspended in minimal essential medium (MEM) and counted in a hemocytometer with a 40  x 
phase objective. The cultures of Y strain contained 85% epimastigotes and 15% trypomastigotes. 
The PF and Tulahuen strains contained 90 and 95% epimastigotes, respectively. Purified trypo- 
mastigotes were obtained as previously described (12) by lysing epimastigotes with fresh guinea 
pig serum (hl0 final dilution in PBS) and recovering the viable trypomastigotes on an albumin 
column  (density  1.085  g.cm  -s) after centrifugation  at  10,000 g  for 40 min.  The parasites  were 
diluted in 5 vol of PBS, washed twice, counted in a hemocytometer, and resuspended to the desired 
concentration in MEM. 
Normal Macrophagcs.  Mouse peritoneal macrophages were obtained from Swiss mice main- 
tained at The Rockefeller University, as well as C3H/He and C57/BL strains obtained from The 
Jackson Laboratory, Bar Harbor, Maine. Cells were harvested according to the methods of Cohn 
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and Benson (15).  They were cultivated on 13-ram round glass cover slips in MEM and 20% heat- 
inactivated (56°C, 30 rain) fetal calf serum (FCS) or horse serum (Grand Island Biological Co.), 100 
U/ml penicillin, and 100 ~zg/ml streptomycin for 24 h  at 37°C before infection. 
Thioglycollate-lnduced Macrophages.  Swiss  Rockefeller  mice  were  injected  intraperitone- 
ally with 1 ml of a  4.05% aqueous solution of Brewer thioglycollate medium (Difco Laboratories, 
Detroit, Mich.), and 4 days later their peritoneal cells were harvested and cultivated as described 
above. 
Cell Lines.  Continuous  cell  lines  were  maintained  as  monolayers  on  Falcon  (Baltimore 
Biological Laboratories, Baltimore, Md.) tissue culture flasks (75 cmS). HeLa cells were provided 
by Dr.  S.  Lazarowitz  and L  cells by Dr.  S.  Silverstein from The  Rockefeller University.  Calf 
embryo fibroblasts were obtained by successive trypsin digestion (37°C,  15 min) of embryonic thigh 
muscles, the cells incubated for 1 h at 37°C, and the nonadherent cell population discarded. After a 
second passage, the cultures consisted entirely of flbreblasts. All cells were kept in FCS-Eagle's 
MEM with antibiotics. Horse serum was used when indicated. The monolayers were cultivated for 
48-72  h  on glass  cover slips for the  infection experiments after removal from the flasks with 
purified trypsin (100/~g/ml in PBS). 
Pratease Treatment of Macrophages.  Trypsin from bovine pancreas Type III No. T-8253 was 
obtained from Sigma Chemical Co., St. Louis, Mo. Macrephage monolayers were incubated for 30 
rain at 37°C with 500 ~g/ml of trypsin in MEM and then washed three times with 500 ftg/ml of 
ovomucoid trypsin inhibitor (Worthington Biochemical Corp.,  Freehold,  N. J.) in MEM to end 
trypsin digestion.  Chymotrypsin no.  06474112  (C.  F.  Boehringer and Sohne Gmblt,  Manheim, 
Germany) treatment was performed as above and digestion terminated by washing the mono- 
layers three times with MEM-50% FCS and again three times with MEM to remove the serum. 
Phase Contrast and Electron Microscopy.  Cover slip cultures were fixed with 1.25% glutaral- 
dehyde in PBS (pH 7.2) for 5 rain at room temperature, washed with distilled water, stained with 
Giemsa stain (Gradwohl Laboratories, Philadelphia, Pa.) for 15 min, and mounted on a glass slide 
for examination by phase  contrast  microscopy  with  a  100  ×  oil  objective.  The  percentage  of 
macrophages infected and the number of parasites per macrophage were obtained by counting a 
minimum of 200 macrophages. Macrophage numbers were determined by counting ten 22,700/~m  z 
microscopic felds  and expressed  as number of macrophages per mm  2.  Observations were  also 
made on unstained specimens fixed in 2.5%  glutaraldehyde and on live preparations observed 
under phase contrast on  a  warm  stage.  The  developmental forms of T.  cruzi  could be easily 
recognized in the stained preparations under phase contrast. Typical epimastigotes have a  wide 
body,  a  kinetoplast  that  is  anterior  to  the  round,  central  nucleus  and  possess  a  long,  free 
flagellum.  Transition forms present a  more  elongated nucleus,  and the kinetoplast is slightly 
posterior to the nucleus. Trypomastigotes possess a  much more slender body (1-2 /zm width), a 
terminal or subtorminal kinetoplast,  an oval  and elongated nucleus,  and a  flagellum that is 
attached along the body forming the undulating membrane. Amastigotes are round or oval (2.4- 
6.5/~m) with a  round central nucleus and are aflagellate (16).  Cells were processed for electron 
microscopy as previously described (17) and examined in a  Siemens Elmiskop 1A. 
Preparation  of Sensitized  Erythrocytes.  Sheep  erythrocytes  (E)  coated  with  anti-E  IgG 
[E(IgG)]  or  IgM  and  complement  [E(IgM)C]  and  the  assay  of ingestion  were  performed  as 
described previously (18,  19). 
Infection of Monolayers.  Cell monolayers on cover slips were washed with MEM and covered 
with 0.05 ml of a  suspension of parasites in MEM-20% FCS for HeLa,  L cells,  and calf embryo 
fibreblasts or in MEM alone when macrophages were used. The cells were then incubated for 90- 
180 min at 37°C.  Parasite/cell ratios were 0.5/1 or 1/1 for macrophages and 5/1 for other cultured 
cells.  With  these  multiplicities  a  sufficient  number of cells  were  infected  to  allow  accurate 
observation without appreciable cell death.  At the end of the exposure period, cover slips were 
washed extensively to remove all extracelluiar parasites and either fixed for microscopic observa- 
tion or replenished with complete medium and incubation continued at 37°C for the desired time. 
Cytochalasin B.  Cytochalasin B was obtained from Aldrich Chemical Co., Inc., Milwaukee, 
Wis., batch no.  PH/2668/77K.  A  1 mg/ml stock solution was prepared in dimethyl sulfoxide and 
diluted to the desired concentration in MEM. Macrophage monolayers were preincubated for 2 h 
with 5 and 10/~g/ml cytochalasin B, then 0.05 ml of a suspension of parasites in the same solution 
was added to the cover slips and incubated for 1 h at 37°C.  Cells were fixed and scored as described 
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IgG Fraction of Rabbit Antiserum  to Mouse Macrophages.  This  reagent  was  prepared  as 
previously described (19, 20) and was kindly supplied by Dr. Frank Griffin (University of Alabama 
Medical Center, Birmingham, Ala.). 0.05 ml of the antiserum IgG fraction was added for 2 h  at 
37°C to 24-h-explanted macrophages. After washing, the cells were infected as described above. 
Results 
The observations were made on three different preparations: (a) mixed popu- 
lation, containing epimastigotes and trypomastigotes, from cultures in Tobie's 
medium; (b)  purified trypomastigotes and transition forms, prepared as  de- 
scribed previously (12); and (c) amastigotes harvested from infected cell cultures 
in 20% FCS. Morphologic features of the forms and details of their preparation 
are given in the Materials and Methods section above. 
Mechanism of Uptake 
MORPHOLOGIC  OBSERVATIONS.  Under phase-contrast microscopy the  early 
interaction of the parasites with macrophages can be seen in Fig.  1.  When a 
mixed population was used as the inoculum (Fig.  1 a), the epimastigotes were 
seen to attach to the surface of macrophages either by means of the flagellum or 
body of the parasite. However, in all instances, ingestion appeared to be initi- 
ated and proceed via the body of the parasite. The interiorized organism was 
often surrounded by a  phase-lucent halo  (Fig.  1 b).  Trypomastigotes also  at- 
tached to the macrophage membrane (Fig.  1 c) and were ingested in a similar 
fashion (Fig.  1 d). With other cultured cells, epimastigotes attached to the cell 
surface but failed to  enter the  cytoplasm.  In contrast,  trypomastigotes and 
transition forms entered HeLa, L cells, and calf embryo fibroblasts. 
An electron microscopic study of these specimens showed that epimastigotes 
(in macrophages) and trypomastigotes entered all cells by a phagocytic mecha- 
nism. No evidence was found at any time of fusion of the parasite and host cell 
membranes or dissolution of the surface membrane at the points of entry. Figs. 
2 a  and b  show,  in specimens fixed 30 min al~r addition of parasites,  early 
stages in the phagocytosis of an epimastigote and a transition form. Figs. 3 a and 
b show epimastigotes and a trypomastigote within phagocytic vacuoles; these 
preparations were fixed 1 h after exposure to the parasites. The surface mem- 
brane of the parasite is clearly identified and the phagocytic vacuole membrane 
is  continuous about the circumference of the parasite.  Fig.  3 b  illustrates  a 
trypomastigote within a  vacuole juxtaposed to  the  nuclear membrane.  The 
migration of vacuoles containing recently ingested trypomastigotes to the par- 
anuclear region was a common occurrence. 
MODIFICATIONS  OF  THE  MACROPHAGE  SURFACE  MEMBRANE.  We  next  em- 
ployed reagents known to influence the expression of macrophage membrane 
receptors and examined their effect on the uptake of T. cruzi. 
EFFECT  OF  PROTEASE  TREATMENT  ON  T.  CRUZI  INGESTION.  Trypsinization 
of macrophages destroys the plasma membrane complement receptor (19, 21) 
and prevents the attachment of giutaraldehyde-treated  red blood cells (22), but 
has no effect on the macrophage Fc receptor. Treatment of normal or thioglycol- 
late-activated macrophages with 500 szg/ml of trypsin completely abolishes the 
attachment and ingestion of both epimastigotes and trypomastigotes without 
impairing the ability of the macrophage to ingest E (IgG) (Tables I, II, and III). FIG.  1.  Phase-contrast micrographs of the interaction of T. cruzi with mouse peritoneal 
macrophages in culture.  (a) Attachment of epimastigotes (arrows) from a mixed population 
to the macrophage surface membrane.  30-rain incubation,  x  2,330.  (b) Ingested epimasti- 
gote (arrow) within a phase-lucent vacuole. 60-min incubation,  x  2,330.  (c) Attachment of 
trypomastigote (arrow) from a purified inoculum to the macrophage surface membrane. 30- 
min incubation,  x  2,560.  (d) Ingested trypomastigotes (arrows) from a purified population. 
60-rain incubation.  ×  1,220.  (e) Macrophage containing several amastigotes (short arrows) 
and fully differentiated trypomastigotes (long arrows) at 96 h  after infection, in 20% horse 
serum,  x  1,330. 
1405 FIo. 2.  Early stages in the phagocytosis of trypanosomes by mouse macrophagee.  2  a 
shows  the  phagocytosis of  an  epimastigote (E)  and  2b  of  a  transition  form  (T)  from  a  purified 
trypomastigote population.  Micropseudopods (arrows)  are  seen  extending  along  the  surface 
of  the parasite.  The membranes of  both the parasite and macrophage appear unaltered. 
Fixed 30  rain  after  the addition  of  parasites.  (a) x 32,000  and (b) × 23,300. 
1406 FIG.  3.  (a)  Epimastigotes (E) from a  mixed inoculum in a  macrophage, 60 min afar the 
addition of parasites.  The two parasites are  seen within a  single phagocytic vacuole,  x 
14,000. The insert shows the clearly defined membranes of the parasite and phagosome,  x 
35,400. (b) Trypomastigote (T) from a purified population within a macrophage, 60 rain after 
the addition of parasites. The membrane of the phagocytic vacuole is clearly seen. × 24,000. 
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TABLE  I 
Uptake of Mixed Populations ofT. cruzi by Normal Macrophages 
Percent of control* 
Pretreatment of macrophages  Culture forms  E(IgM)C attach- 
ingestion  E (IgG) ingestion  ment 
Trypsin  2  98  22 
Antimacrophage, IgG  44  10  Not done 
Untreated (Control)  100  (28)  100  (87)  100  (78) 
* Numbers in parenthesis represent actual values in control samples, expressed as percent of cells 
which ingested or attached the corresponding particles. 180-rain incubation. 
* IgG fraction of rabbit antiserum to mouse macrophages. 
TABLE  II 
Uptake of Purified Trypomastigotes by Normal Macrophages 
Percent of  control* 
Pretreatment of macrophages  Purified trypo-  E(IgM)C attach- 
mastigotes  E (IgG) ingestion  ment 
ingestion 
Trypsin  4  97  10 
Chymotrypsin  18  79  113 
Antimacrophage* IgG  51  9  Not done 
Untreated (control)  100  (37)  100  (96)  100  (97) 
* Numbers in  parenthesis represent actual  values  in  control  samples, expressed as  percent of  cells 
which ingested or attached the corresponding particles.  180-min incubation. 
IgG fraction  of  rabbit antiserum to mouse macrophages. 
However, chymotrypsin (500 /~g/ml)  treatment of normal and thioglycollate- 
activated  macrophages,  which we  found not to  affect  C3  receptor-mediated 
binding or ingestion (Tables II and III), also abolished the binding and ingestion 
of epimastigotes and trypomastigotes. This rules out a requirement for the C3 
receptor for  parasite  ingestion.  Although pretease  treatment  inhibited the 
ingestion of both epimastigotes and trypomastigotes, it is not known whether 
the same receptor is involved in the uptake of the two forms. 
EFFECT  OF IgG FRA(~TION OF RABBIT ANTISERUM  TO  MOUSE  MACROPHAGES ON T. 
CRUZ/INGESTION.  The IgG fraction of an antiserum directed against the macro- 
phage plasma membrane blocks ingestion mediated by the Fc receptor, but has 
no effect upon ingestion of  formaldehyde-treated  erythrocytes, zymosan, or latex 
particles  (20). Macrophages pretreated with IgG antimacrophage antibodies 
were  still  capable  of ingesting epimastigotes or trypomastigotes albeit  to  a 
degree less than that of untreated cells. Under these conditions, the uptake of 
IgG-coated erythrocytes is completely inhibited  (Tables  I  and H).  Since the 
purification of trypomastigotes required a serum-treatment step, the possibility 
existed that some adsorption of IgG had occurred, mediating uptake by the Fc 
receptor. To evaluate this, mixed populations of untreated parasites were stud- 
ied in comparison with those incubated with fresh guinea-pig serum, as per- 
formed before the purification procedure. No significant difference in the inges- 
tion of such serum-treated parasites by IgG antimacrophage-treated cells was NADIA  NOGUEIRA  AND  ZANVIL  COHN 
TABLE  III 
Uptake of Purified Trypomastigotes by ThioglycoUate-Induced 
Macrophages 
1409 
Percent of control* 
Pretreatment  of macro- 
Purified try-  E(IgG)  inges-  E(IgM)C 
phages  pemastigotes  tion  ingestion 
ingestion 
Trypsin  7  87  5 
Chymotrypsin  28  79  91 
Untreated (control)  10O (23)  100 (93)  100 (32) 
* Numbers in parenthesis  represent  actual values in control samples, ex- 
pressed as percent of  cells which ingested the corresponding particles. 90-min 
incubation. 
found. Since the specificities of the antimacrophage antiserum are not known, it 
is  possible that  the  inhibition  is  due  either  to  steric  interference  or  to  the 
presence of antibodies directed against specific attachment sites for the parasite 
on the macrophage surface membrane. 
EFFECT  OF  CYTOCHALASIN  B  ON  THE  INGESTION OF T.  CRUZ1 BY MOUSE  PERITO- 
NEAL MACROPHAGES.  The antibiotic cytochalasin B has been shown (23, 24) to 
reversibly inhibit phagocytosis of various particles by mouse peritoneal macro- 
phages.  Cytochalasin B  (5-10/~g/ml) blocked completely the ingestion of both 
epimastigotes  and  purified  trypomastigotes  by macrophages,  but the  attach- 
ment of the parasites  to the macrophage plasma membrane  was not altered. 
Parasite motility was unaffected by the drug concentrations used. Removal of 
cytochalasin B promptly allowed many of the attached parasites to be ingested 
and subsequent intracellular  multiplication ensued, thus indicating that para- 
site viability was not altered by exposure to these drug concentrations. 
Intracellular  Fate 
INTRACELLULAR GROWTH.  Phase  contrast  observations  on  live  cultures 
(warm stage) showed that when the mixed population of parasites were used, 
epimastigotes remained motile for minutes after the ingestion process had been 
completed.  Later,  parasite  motility completely ceased, progressive disintegra- 
tion of the epimastigotes ensued,  and by 24 h  no further  morphologic details 
could  be  seen.  At  24  h  all  the  surviving  parasites  had  the  appearance  of 
amastigotes.  These amastigotes subsequently multiplied intracellularly  in the 
presence of 20% FCS, whereas if 20% horse serum was employed, multiplication 
of amastigotes was followed by a  much greater differentiation into trypomasti- 
gotes (Fig.  1 e). 
A quantitative evaluation of these results with a mixed population inoculum 
is presented in the growth curve of Fig. 4 a. In the first 24 h aider infection there 
was a  sharp  decline in the number of parasites/100  macrophages  and in the 
number of macrophages containing morphologically intact parasites.  This was 
correlated with the morphological disintegration of epimastigotes and the sur- 
vival of a  few amastigotes.  With the ratios of parasite/cell used there was no 
significant  loss in the cell number during the period of observation  (Fig.  4 a; 
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was probably occurring, since the number of infected  macrophages increases 
progressively  (Fig.  4  a; middle).  The number of  parasites/100  rnacrophages also 
increased  progressively  with a doubling time of  approximately 15 h. 
The possibility  that  the surviving amastigotes in  these cultures  were derived 
from the 15% trypomastigotes present in the mixed inoculum prompted us to 
study macrophage cultures  infected  with purified  trypomastigotes.  In contrast 
to  the epimastigotes,  the majority of  the trypomastigotes remained morphologi- 
cally  intact  and began to  multiply intracellularly.  Fig.  4  b illustrates  the behav- 
ior of trypomastigotes within macrophages.  No sharp decline in either the 
number of  parasites/100  macrophages or the number of  infected  macrophages 
occurred.  The number of  parasites/100  macrophages increased  with a doubling 
time of  approximately 15 h, the same as that observed for  the surviving para- 
sites  in  the cultures  exposed to mixed forms,  discussed  above. In  the  presence of 
20% FCS little  intracellular  differentiation  into  trypomastigotes occurred,  and 
amastigotes were released  into  the medium. These were subsequently phagocy- 
tized by macrophages, thereby propagating the infection.  Behbehani (7) had 
observed a similar uptake of released amastigotes  in vitro. As mentioned 
previously, use of 20% horse serum led to differentiation  of amastigotes into 
trypomastigotes, and the latter  were released upon cell  rupture. The same 
growth curves were observed with peritoneal  macrophages from C3H/He and 
C57/BL mice and with the Tulahuen and PF strains  of  T. cruzi. 
FIG. 4.  The behavior of  T. cruzi within unstimulated mouse peritoneal  macrophages. (a) 
shows the fate  of  mixed populations and (b)  of  purified  trypomastigotes. The percentage of 
macrophages initially  infected  expresses the number of  cells  containing one or  more intact 
parasites  at subsequent time points  as compared to  the number at the end of  the infecting 
pulse (100%). Cells  were exposed to parasites for 90 rain  in (a) or 180 rain  in (b) before 
removal  of  extracellular  organisms. The continuous  line  represents a  parasite/cell  ratio  of  1/ 
2 and the dashed line  1/1. NADIA  NOGUEIRA  AND  ZANVIL  COHN  1411 
FATE IN THIOGLYCOLLATE-ACTIVATED MACROPHAGES.  Thioglycollate-induced 
macrophages, as well as macrophages obtained from animals systemically in- 
fected with bacillus Calmette-Guerin (BCG), display biochemical and functional 
properties different from their normal counterparts (15, 19, 25-29). Thioglycol- 
late-activated macrophages ingested twice as many epimastigotes or trypomas- 
tigotes as normal resident cells did, but the subsequent intracellular fate and 
rate of growth of the surviving parasites was the same as in normal cells. 
Thioglycollate-activated macrophages,  therefore, are  not  able  to  resist  and 
contain intracellular infection by T.  cruzi  as  has  been described for  BCG- 
activated macrophages (30-32). 
DESTRUCTION  OF  EPIMASTIGOTES  IN  THE  PHAGOCYTIC  VACUOLE  OF  MACRO- 
PHAGES.  Ultrastructural observation of cells infected with mixed populations, 
fixed at  6  h,  showed nearly all  intracellular parasites  in  various stages  of 
degradation within phagocytic vacuoles (Fig. 5). If  macrophages  were prelabeled 
with Thorotrast according to the technique described by Jones and Hirsch (33), 
the marker was found inside the vacuoles, indicating delivery of the contents of 
secondary lysosomes into the epimastigote-containing vacuoles. 
ESCAPE  OF  TRYPOMASTIGOTES AND TRANSITION FORMS  FROM THE  PHAGOCYTIC 
VACUOLE.  Electron microscopic examination of cultures infected with purified 
trypomastigotes showed these forms initially inside phagocytic vacuoles (Fig. 
3 b, 60 rain). At later times, all the parasites were seen free in the cytoplasm 
(Fig.  6) and were often in close  association with strips of rough endoplasmic 
reticulum. No evidence of the endocytic vacuole was observed. The parasite 
membrane was clearly defined as evidenced by the array of subpellicular micro- 
tubules (Fig. 7). 
The mechanism by which the phagocytic vacuole membrane disappears is 
unknown. However, in rare instances, the parasite was seen inside a phagocytic 
vacuole with a  modified vacuolar membrane having a  thickness of approxi- 
mately half the usual unit membrane, as early as 90 rain alter addition of the 
parasites (Fig. 8). 
EPIMASTIGOTES AND TRYFOMASTIGOTES IN OTHER CULTURED CELLS.  Epimasti- 
gotes were not taken up  by HeLa,  L  cells,  and calf embryo fibreblasts.  In 
contrast, transition forms and trypomastigotes, as well as released Amastigotes, 
were ingested by all cell types. The ingested trypomastigotes and transition 
forms were found inside phagocytic vacuoles at early times ai~r infection, as is 
seen in Fig. 9 for an L cell, and later free in the cytoplasmic matrix, as shown in 
Fig. 10 for a calf embryo fibroblast. 
Discussion 
The experiments presented in this report indicate that the uptake of Try- 
panosoma cruzi by mammalian cells occurs by a phagocytic process. This is the 
case both for the  ingestion of epimastigotes and trypomastigotes by macro- 
phages and the entry of trypomastigotes and transition forms into "nonprofes- 
sional" phagocytes. The mechanism of entry of T. cruzi is thus similar to that 
of  malarial  merozoites  into  erythrocytes  (34), of  Toxoplasma  gondii  into 
macrophages and fibroblasts (33, 35), and of Leishmania donovani into macro- 
phages (36). 
The integrity of the macrophage plasma membrane was always preserved 1412  TRYPANOSOMA  CRUZI 
FIG. 5.  Epimastigetes (E) within phagosomes in different stages of digestion. Fixed 6 h 
after  the  addition  of parasites,  x  14,000. Insert,  high  magnification of the  phagocytic 
vacuole membrane. The membrane of the parasite is easily identified by the presence of the 
subpellicular microtubules.  × 46,000. 
during the ingestion process. In contrast,  Sooksri and Inoki (11),  studying the 
penetration of T. cruzi in HeLa cells, have interpreted their results as indicat- 
ing an entry mechanism involving dissolution of the plasma membrane.  How- 
ever, their micrographs seem to show typical phagocytic figures with finger-like 
protrusions of the HeLa cell around trypomastigotes, and trypomastigotes com- 
pletely surrounded by a phagocytic vacuole membrane. 
The presence of a  protease-sensitive component on the macrophage plasma 
membrane,  necessary for uptake of T. cruzi,  suggests that  such a  membrane 
structure may also exist in other cell types, but this has not yet been studied. It 
is possible that these components determine the tropism of T. cruzi for different 
tissues. Previous studies have shown that the C3 receptor is sensitive to trypsin 
(19,  21).  Extending these observations we have found that the macrophage C3 
receptor  is  insensitive  to  chymotrypsin,  while  the  receptors  for T.  cruzi  are 
sensitive to both trypsin  and  chymotrypsin.  This  allowed us to rule  out any 
involvement  of the  C3  receptor  on  the  interiorization  of T.  cruzi  under  the 
experimental  conditions  used.  Likewise,  the  receptor  for  immunoglobulin  G 
does not  seem  to  be  involved  under  the  present  conditions.  However,  these 
receptors may play a role in the presence of specific antibody and complement, 
and this situation is being investigated. NADIA  NOGUEIRA  AND  ZANVIL  COHN  1413 
FIG.  6.  Appearance of parasites at 48 h  after macrophage infection. The organisms are 
free in the cytoplasmic matrix, and the phagosome membrane is absent,  x  13,000. 1414  TRYPANOSOMA  CRUZI 
Fzo.  7.  High magnification of an intracellular parasite 48 h  after macrophage infection, 
showing the typical unit-membrane structure of the parasite membrane (arrow), underly- 
ing subpellicular microtubules and absence of host membrane. Strips of rough endoplasmic 
reticulum (RER)  are close]y apposed to the parasite, x  46,000. NADIA  NOGUEIRA  AND  ZANVIL  COHN  1415 
FIG. 8.  Transverse  section  through an intracellular parasite (T), 90 min after macrophage 
infection  with purified  trypomastigotes.  The parasite membrane (short arrow) has a typical 
unit membrane structure with underlying subpellicular microtubules. Another modified 
membrane is also seen around the parasite which is thinner and has only  a single leaflet 
(dashed arrow). × 38,500. The insert illustrates this difference  at higher magnification.  The 
short arrow marks the membrane  of the parasite and the long arrow an adjacent, typical 
phagosome (P) membrane. × 62,700. 
A striking inhibition of the uptake of culture forms of T. cruzi by 5-10/~g/ml 
of  cytochalasin B was also noted by Alexander (37). He argued that the failure of 
cytochalasin B to completely inhibit parasite uptake was consistent with active 
penetration of the macrophages by the parasites. In our hands, similar concen- 
trations of cytochalasin B completely blocked the uptake of both epimastigotes 
and purified trypomastigotes by macrophages without affecting their attach- 
ment to the cells or their subsequent entry into cells after removal of cytochal- 
asin B. These results are consistent with a classical endocytic mechanism for the 
interiorization of these organisms. 
Epimastigotes were capable of attaching to, but not entering ~nonprofessional 
phagocytic" cells, whereas trypomastigotes and transition forms entered all cell 
types  studied.  This  could  be  explained  by  a  difference in  the  cell  surface 
receptors for epimastigotes and trypomastigotes or by the fact that the ingestion 
process requires a  more active role for the parasites, a  quality lacking in the 
epimastigotes. 
Trypomastigotes and transition forms are able to survive the interaction with FIG.  9.  A section through the kinetoplast (K) of a trypomastigote (T) within an L cell fixed 
3 h  after addition of the parasites. At this time, the phagosome membrane (arrow) clearly 
surrounds the parasite,  x  55,000. 
FIG.  10.  Parasites in a  calf embryo fibroblast fixed 60 h  after ingestion. Amastigotes (A) 
are  seen  free  in  the  cytoplasm,  x  18,400.  Insert,  high  magnification  of the  parasite 
membrane  (short arrow)  and  absence of the phagosome.  Microfilaments are  seen  (long 
arrow) between the developing organisms.  ×  45,000. 
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macrophages and other  cell  types,  escape from the  phagocytic  vacuole, and then 
multiply in the cytoplasmic matrix.  This is in contrast with Toxoplasma, 
Leishmania, and malarial  trophozoites,  which multiply  within  phagocytic  vacu- 
oles.  A similar process of  escape from the  phagocytic vacuole has  been described 
for  a number of  animal viruses (38,  39).  In  the case of  vaccinia viru§ it  has been 
found (38)  that opsonization of  the  virus particle  with specific  antibody prevents 
the  escape  from the  phagocytic  vacuole, and the  virus is  then killed  and digested 
by lysosemal enzymes. Perhaps specific  antibody on the surface of  trypomasti- 
gotes might similarly interfere  with escape from the phagocytic vacuole, and 
this  possibility  is  being investigated. 
The mechanism  by which the trypomastigote interacts with the host cell 
vacuolar membrane  promoting its disappearance is not yet clear. Possible 
mechanisms might represent lysis  of  the phagosome membrane by a parasite- 
released factor  or some more direct  membrane-membrane  interaction.  It is  not 
clear if  the process is one of complete dissolution  of  the membrane or a more 
limited reaction in which disrupted membrane is  ultimately disposed of  by the 
cell. We tend to favor the first  possibility  in view of the finding of modified 
membranes as is shown in Fig. 8 and on the fact  that no membrane remnants 
were seen in the course of this study. In addition, we do not know if the 
phagosomes  containing trypomastigotes or transition forms fuse with lyso- 
somes before the membrane alteration. 
The situation with epimastigotes is quite different and after  fusion with 
lysosomes has occurred, complete digestion of  the parasites ensues. This result 
is in keeping with the microscopic observations of  Pizzi  et al. (40,  41) in which 
only the trypomastigotes were able to survive an in vivo interaction with 
macrophages. However, others have reached  different  conclusions (8,  42).  In  this 
regard, it is important to realize  that transition  forms are also  able to survive 
lysis  by normal fresh  serum (12)  and therefore  behave functionally  as  trypomas- 
tigotes  in terms of  uptake, fate,  and sensitivity  to lysis.  This fact  may explain 
some of the discrepancies in the literature on the role of epimastigotes in 
infection.  The fate  of  amastigotes, trypomastigotes, and transition  forms may be 
different in immune  and normali macrophages, as suggested by the in vitro 
results  of  Hoff  (32)  for  mixed population  of  parasites  and from  the  in  vivo  studies 
of  Scorza (43).  In thioglycollate-activated  macrophages, however, no alteration 
in their  fate  was observed. 
A previous  report  on  the  interaction  of  culture  forms and  blood  form trypomas- 
tigotes  in hamster macrophages (44)  has reached opposite conclusions.  Epimas- 
tigotes were thought to be free in the cytoplasm, whereas trypomastigotes 
were contained within a vacuole. The finding of trypomastigotes within a 
phagocytic vacuole at 1 h after  infection  is consistent with our results;  how- 
ever,  at  later  times we would expect them to  be free  in  the cytoplasm. The find- 
ing of  epimastigotes free  in the cytoplasm may be the result  of  poor membrane 
preservation during the processing of  the specimens. 
The availability  of a purified  population of trypomastigotes allowed us to 
establish  the mechanism of  uptake and the fate  of  the two culture forms of  T. 
cruzi.  The  use of  mixed populations  obtained  from cultures  is  not  appropriate  for 
in vitro  work, since  the majority of  the population is  composed of  epimastigotes 1418  TRYPANOSOMA  CRUZI 
that are unable to  survive in  the macrophage and are  unable to  penetrate other 
cell  types.  This makes it  difficult  to  quantitatively assess  uptake and intracellu- 
lar survival of  the parasites at early times.  Epimastigotes are probably nonin- 
fectious  in vivo for other reasons as well,  since they can activate the alternate 
pathway of  complement in the absence of  specific  immunoglobulin (12)  and are 
lysed in normal serum. The observed uptake by macrophages and other cul- 
tured cells  and intracellular  development of released amastigotes imply that 
these forms are also  infective  and may play a role  in the pathogenic process in 
vivo. 
Summary 
The mode of  entry and intracellular fate of epimastigotes and trypomastigotes 
of Trypanosoma cruzi in cultured cells was studied. Electron microscopic obser- 
vations indicated the uptake by phagocytosis of both forms into mouse perito- 
neal macrophages and of trypomastigotes and transition forms into other cul- 
tured cell types. In each instance the organisms were initially surrounded by a 
plasma membrane-derived phagoseme. Trypsin and chymotrypsin treatment of 
the macrophages completely abolished attachment and ingestion of both forms, 
indicating that protease-sensitive structures on the macrophage plasma mem- 
brane mediate ingestion. The macrophage Fc or C3b receptors were not essential 
for uptake of T. cruzi in the conditions used. Cytochalasin B inhibited ingestion 
but not the attachment of both forms by macrophages. 
Epimastigotes were not taken up by HeLa, L  cells,  and calf embryo fibro- 
blasts. In macrophages, epimastigotes were killed and digested within phagoly- 
sosemes.  In contrast, trypomastigotes and transition forms escaped from the 
phagocytic vacuole and then multiplied in the cytoplasmic matrix. Amastigotes 
released from infected cells exhibited properties similar to those of trypomasti- 
gotes and were able to enter all cell types studied and multiply intracellularly. 
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